Syenex
Evanston, IL · Biotechnology · 11 employees
Syenex is a synbio technology company that provides genetic medicine developers with access to best-in-class targeted delivery technologies (ex vivo & in vivo). Our goal is to accelerate clinical impact for developers of curative cell and gene therapies
Funding history
- Funding Round — $8.7M — Jan 2025
- Funding Round — $5.0M — Sep 2022
- Series pre-seed — $5.0M — Jul 2022
Recent signals
- Jan 27, 2025: Raised $8.7M
- Sep 07, 2022: Raised $5.0M
- Jul 13, 2022: Raised $5.0M in Series pre-seed
See plans & pricing → Track Syenex’s funding, hiring, and signals — with verified contacts — on Fundz.